InvestorsHub Logo
Followers 33
Posts 2049
Boards Moderated 0
Alias Born 11/06/2011

Re: ah86 post# 31951

Thursday, 02/24/2022 2:05:45 PM

Thursday, February 24, 2022 2:05:45 PM

Post# of 34625
I get it. Everyone always wants a partnership or buyout when in reality that's not as common as everyone makes it out to be. I've said it for the longest time that the best chance at a partnership here is going to be in pancreatic or other solid tumor indications. The company sponsored trial in pancreatic will be what dictates if a partnership materializes in the future. Feel free to disagree with me.

Sure, Marker could run out and beg BP for a partnership right now and while it would be nice I wouldn't hold out hope for that. I can almost guarantee that most bio companies would rather build their company into the next BP rather than sell out so early on. The reality is that if they can produce the goods someone will come knocking soon enough.

To facilitate any partnership or buyout the company needs to produce data. No one is going to bring up front cash without it. They don't have enough data right now to warrant a buyout unless you want it to be for peanuts.

Friends don't let friends place market orders

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News